You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Wild-type P53

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Solid Tumor Trial in United States (ASTX295)

Recruiting
  • Solid Tumor
  • Duarte, California
  • +9 more
Nov 18, 2022

Endometrial Cancer Trial in Israel, United States (Selinexor, Matching Placebo for selinexor)

Recruiting
  • Endometrial Cancer
  • Miami Beach, Florida
  • +6 more
Jan 31, 2023

Advanced Soft-tissue Sarcoma, Metastatic Soft-tissue Sarcoma Trial in France (Pazopanib, HDM201)

Recruiting
  • Advanced Soft-tissue Sarcoma
  • Metastatic Soft-tissue Sarcoma
  • Bordeaux, France
  • +4 more
May 5, 2022

Malignant Salivary Gland Cancer, Salivary Gland Cancer Trial in Tampa, Chicago, Ann Arbor (APG-115, Carboplatin)

Recruiting
  • Malignant Salivary Gland Cancer
  • Salivary Gland Cancer
  • Tampa, Florida
  • +2 more
Feb 10, 2022

Merkel Cell Carcinoma Trial in Worldwide (KRT-232, Avelumab)

Recruiting
  • Merkel Cell Carcinoma
  • Aurora, Colorado
  • +38 more
Aug 3, 2022

Solid Tumor With p53 Wild Type Status Trial in Worldwide (CGM097)

Completed
  • Solid Tumor With p53 Wild Type Status
  • Boston, Massachusetts
  • +4 more
Jun 10, 2021

Anemia, Recurrent Plasma Cell Myeloma, Refractory Plasma Cell Myeloma Trial in Atlanta, Columbus, Salt Lake City (drug, other,

Active, not recruiting
  • Anemia
  • +2 more
  • Atlanta, Georgia
  • +2 more
Jan 28, 2023

Resectable Soft Tissue Sarcoma, Soft Tissue Sarcoma Trial in United States (Navtemadlin, Radiation Therapy)

Recruiting
  • Resectable Soft Tissue Sarcoma
  • Soft Tissue Sarcoma
  • Goodyear, Arizona
  • +52 more
Jul 21, 2022

Recurrent Plasma Cell Myeloma, Refractory Plasma Cell Myeloma Trial in Los Angeles (drug, other, biological)

Active, not recruiting
  • Recurrent Plasma Cell Myeloma
  • Refractory Plasma Cell Myeloma
  • Los Angeles, California
    USC / Norris Comprehensive Cancer Center
Aug 5, 2022

Pediatric Cancer, Li-Fraumeni Syndrome, p53 Mutations Trial in Guangzhou (Arsenic trioxide)

Not yet recruiting
  • Pediatric Cancer
  • +2 more
  • Arsenic trioxide
  • Guangzhou, Guangdong, China
    Sun Yat-sen Memorial Hospital, Sun Yat-sen University
Oct 12, 2023

Pancreatic Tumors, Solid Tumors, Biliary Tract Cancer Trial (BI 907828)

Not yet recruiting
  • Pancreatic Neoplasms
  • +2 more
  • BI 907828
  • (no location specified)
Aug 22, 2022

Metastatic Colon Cancer Trial in Italy (Trifluridine Tipiracil, Panitumumab 20 MG/1 ML Intravenous Solution [VECTIBIX])

Completed
  • Metastatic Colon Cancer
  • Trifluridine Tipiracil
  • Panitumumab 20 MG/1 ML Intravenous Solution [VECTIBIX]
  • Monserrato, CA, Italy
  • +7 more
Jul 21, 2022

Solid Tumor, Lymphoma, Peripheral T-Cell Lymphoma Trial in United States (ALRN-6924)

Completed
  • Solid Tumor
  • +2 more
  • Birmingham, Alabama
  • +12 more
Jul 13, 2020

Metastatic Colorectal Cancer Trial in Italy (Cetuximab, Avelumab)

Recruiting
  • Metastatic Colorectal Cancer
  • Ancona, Italy
  • +23 more
Oct 25, 2022

NSCLC Trial in China (JAB 21822)

Recruiting
  • Non-small Cell Lung Cancer
  • JAB 21822
  • Beijing, Beijing, China
  • +20 more
Sep 26, 2022

Polyneuropathy, Amyloidosis Trial in Jette (ECG + echocardiography, Answering questionnaires)

Recruiting
  • Polyneuropathy
  • Amyloidosis
  • ECG + echocardiography
  • Answering questionnaires
  • Jette, Belgium Capital City, Belgium
    UZ Brussel
Jul 14, 2023

P53 Mutation, Myeloid Malignancy, MDS Trial in Shanghai (Decitabine, Arsenic Trioxide)

Recruiting
  • P53 Mutation
  • +3 more
  • Shanghai, Shanghai, China
    Hematological department, Shanghai Institute of Hematology, Ruij
Apr 20, 2021

Advanced Solid and Hematological TP53wt Tumors Trial in Worldwide (HDM201, ancillary treatment)

Completed
  • Advanced Solid and Hematological TP53wt Tumors
  • Boston, Massachusetts
  • +14 more
May 20, 2021

Colon Cancer, Colorectal Cancer, Rectal Cancer Trial in Worldwide (Panitumumab, Bevacizumab, mFOLFOX6)

Completed
Has Results
  • Colon Cancer
  • +3 more
  • Birmingham, Alabama
  • +94 more
Nov 10, 2022

Advanced BRAFV600 Wild-type Melanoma Trial in Worldwide (Cobimetinib, Atezolizumab, Pembrolizumab)

Terminated
Has Results
  • Advanced BRAFV600 Wild-type Melanoma
  • Tucson, Arizona
  • +120 more
Aug 24, 2022

Advanced Solid Tumor, CDKN2A, NSCLC Trial (Milademetan, Atezolizumab)

Withdrawn
  • Advanced Solid Tumor
  • +9 more
  • (no location specified)
Oct 16, 2023

Colorectal Carcinoma, Ulcerative Colitis Trial in Chicago (Atorvastatin Calcium, Biospecimen Collection, Placebo Administration)

Recruiting
  • Colorectal Carcinoma
  • Ulcerative Colitis
  • Atorvastatin Calcium
  • +2 more
  • Chicago, Illinois
    Northwestern University
Feb 10, 2022

Melanoma (Skin) Trial in Baltimore (pentamidine)

Terminated
Has Results
  • Melanoma (Skin)
  • Baltimore, Maryland
    Greenebaum Cancer Center at University of Maryland Medical Cente
Aug 14, 2019

MRI Radiomics Combined With Pathomics on Prediction of Molecular

Not yet recruiting
  • Endometrial Neoplasms
  • next generation sequencing AND Immunohistochemical examination
  • Fuzhou, Fujian, China
    Clinical Oncology School of Fujian Medical University, Fujian Ca
Nov 13, 2023

Unusual Infiltrative Patterns of Malignant Cells in Endometrial

Not yet recruiting
  • Endometrial Cancer
    • (no location specified)
    Mar 11, 2023